From left to right: Sergio Duron, chief scientific officer of Calporta; Jay Lichter, managing director of Avalon Ventures; Tighe Reardon, chief financial officer of Calporta; and Sanford Madigan, CEO of Calporta. Photo courtesy of Calporta Therapeutics Inc.

From left to right: Sergio Duron, chief scientific officer of Calporta; Jay Lichter, managing director of Avalon Ventures; Tighe Reardon, chief financial officer of Calporta; and Sanford Madigan, CEO of Calporta. Photo courtesy of Calporta Therapeutics Inc.

In 2017, Merck & Co...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129